Drugs Made In America Acquisition II Ord Shs

根据Drugs Made In America Acquisition II Ord Shs的FY2025财报，流动资产为26.04K（同比变化-56.32）。

根据Drugs Made In America Acquisition II Ord Shs的FY2025财报，Drugs Made In America Acquisition II Ord Shs的总资产为504.96M（同比变化365643.31）。

根据Drugs Made In America Acquisition II Ord Shs的FY2025财报，Drugs Made In America Acquisition II Ord Shs的总负债为17.80M（同比变化6886.68）。

根据Drugs Made In America Acquisition II Ord Shs的FY2025财报，Drugs Made In America Acquisition II Ord Shs的总权益为487.16M（同比变化417477.61）。

根据Drugs Made In America Acquisition II Ord Shs的FY2025财报，Drugs Made In America Acquisition II Ord Shs的净融资为501.00M（同比变化236966.17）。

根据Drugs Made In America Acquisition II Ord Shs的FY2025财报，每股收益（EPS）为0.32（同比变化10745.61）。

根据Drugs Made In America Acquisition II Ord Shs的FY2025财报，营业利润为-488.38K（同比变化-221.90）。